H Vogelsang|D Kirsch - JoVE Visualize

Showing results (161-170 of 401) with videos related to

Pageof 41

Sort By:

Schmerz (Berlin, Germany)|September 1, 1988

[Measurement of pain.]E V Gablenz, B Heinen, D Kirsch, et al.

Diabetologia|June 1, 1984

Extrapancreatic action of the sulphonylurea gliquidone: post-receptor effect on insulin-stimulated glycogen synthesis in rat hepatocytes in primary cultureF Rinninger, D Kirsch, H U Häring, et al.

Biological Chemistry|August 1, 1998

Prion rods contain small amounts of two host sphingolipids as revealed by thin-layer chromatography and mass spectrometryT R Klein, D Kirsch, R Kaufmann, et al.

Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|August 1, 1979

[Bicycle ergometric testing in the acute phase of liver disease with particular reference to changes in serum enzymes]C Metzner, K Ziesenhenn, W D Kirsch, et al.

Alimentary Pharmacology & Therapeutics|June 6, 2003

An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgiaW Reinisch, W Miehsler, C Dejaco, et al.

Allergie Und Immunologie|January 1, 1985

[The quantitative determination of the IgM rheumatoid factor using a solid-phase radioimmunoassay. Comparison with the agglutination test and the radioimmuno-polyethyleneglycol precipitation test]D Herrmann, L Jäger, G Hein, et al.

Zeitschrift Fur Gastroenterologie|August 19, 2007

[Use of infliximab in ulcerative colitis]H Tilg, T Feichtenschlager, P Knoflach, et al.

Digestive Diseases and Sciences|July 1, 1989

Bone disease in vitamin D-deficient patients with Crohn's diseaseH Vogelsang, P Ferenci, W Woloszczuk, et al.

Zeitschrift Fur Gastroenterologie|February 4, 2014

[Adalimumab for the treatment of ulcerative colitis--a consensus report by the working group inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology]G Novacek, C Dejaco, P Knoflach, et al.

Clinical Nephrology|October 3, 2002

Determination of autofluorescence of red blood cells (RbCs) in uremic patients as a marker of oxidative damageG Stoya, A Klemm, E Baumann, et al.

Pageof 41

Showing results (161-170 of 401) with videos related to

Sort By:

Pageof 41

Schmerz (Berlin, Germany)|September 1, 1988

[Measurement of pain.]E V Gablenz, B Heinen, D Kirsch, et al.

Diabetologia|June 1, 1984

Extrapancreatic action of the sulphonylurea gliquidone: post-receptor effect on insulin-stimulated glycogen synthesis in rat hepatocytes in primary cultureF Rinninger, D Kirsch, H U Häring, et al.

Biological Chemistry|August 1, 1998

Prion rods contain small amounts of two host sphingolipids as revealed by thin-layer chromatography and mass spectrometryT R Klein, D Kirsch, R Kaufmann, et al.

Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|August 1, 1979

[Bicycle ergometric testing in the acute phase of liver disease with particular reference to changes in serum enzymes]C Metzner, K Ziesenhenn, W D Kirsch, et al.

Alimentary Pharmacology & Therapeutics|June 6, 2003

An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgiaW Reinisch, W Miehsler, C Dejaco, et al.

Allergie Und Immunologie|January 1, 1985

[The quantitative determination of the IgM rheumatoid factor using a solid-phase radioimmunoassay. Comparison with the agglutination test and the radioimmuno-polyethyleneglycol precipitation test]D Herrmann, L Jäger, G Hein, et al.

Zeitschrift Fur Gastroenterologie|August 19, 2007

[Use of infliximab in ulcerative colitis]H Tilg, T Feichtenschlager, P Knoflach, et al.

Digestive Diseases and Sciences|July 1, 1989

Bone disease in vitamin D-deficient patients with Crohn's diseaseH Vogelsang, P Ferenci, W Woloszczuk, et al.

Zeitschrift Fur Gastroenterologie|February 4, 2014

[Adalimumab for the treatment of ulcerative colitis--a consensus report by the working group inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology]G Novacek, C Dejaco, P Knoflach, et al.

Clinical Nephrology|October 3, 2002

Determination of autofluorescence of red blood cells (RbCs) in uremic patients as a marker of oxidative damageG Stoya, A Klemm, E Baumann, et al.

Pageof 41